MedPath

Taiwan Diabetes Registry

Recruiting
Conditions
Diabetes Mellitus
Registration Number
NCT06143449
Lead Sponsor
The Diabetes Association of the Republic of China (Taiwan)
Brief Summary

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease,Macrovascular Disease and Neuropathy in Patients With Diabetes.

Detailed Description

At the first year (2015), the patients ever enrolled into the quality control study by Taiwan Association of Diabetes Educators in 2006 and 2011 will be recruited, and their relevant clinical data will be regularly registered yearly until 2030. In addition, it is planned that type 1 diabetic patients will be enrolled, and their clinical data will be regularly recorded yearly until 2030. Also, newly diagnosed type 2 diabetic patients will be recruited, and their clinical data will be regularly entered to the diabetes web-based system yearly until 2030. We will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030. Finally, we will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24000
Inclusion Criteria
  • Diagnosis of diabetes mellitus
Exclusion Criteria
  • Patients who do not have diabetes mellitus
  • Participating in an interventional trial requiring informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Provide data on disease management.Ten years
Provide data on patient characteristicsTen years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Diabetes Association of the Republic of China (Taiwan)

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath